![Chemical structure of 1-Butanone, 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-, CAS 1649-18-9](https://api.angenesci.com/structure/2597/1649-18-9.png)
无数据
无数据
无数据
| CAS Number | 1649-18-9 |
| Catalog Number | AG001V4Y(AGN-PC-0JKCAT) |
| Chemical Name | 1-Butanone, 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]- |
| EC Number | 216-715-8 |
| IUPAC Name | 1-(4-fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-1-one |
| InChI | InChI=1S/C19H22FN3O/c20-17-8-6-16(7-9-17)18(24)4-3-11-22-12-14-23(15-13-22)19-5-1-2-10-21-19/h1-2,5-10H,3-4,11-15H2 |
| InChI Key | XTKDAFGWCDAMPY-UHFFFAOYSA-N |
| MDL Number | MFCD00866692 |
| Molecular Formula | C19H22FN3O |
| Molecular Weight | 327.3959 |
| SMILES | O=C(C1=CC=C(F)C=C1)CCCN2CCN(C3=NC=CC=C3)CC2 |
| UNII | 19BV78AK7W |
| Synonyms | Azaperone,
R-1929,
R1929,
Stresnil,
Azaperone,
1649-18-9,
Stresnil,
Azaperon,
Fluoperidol,
Suicalm,
Azeperone,
Eucalmyl,
Sedaperone vet,
Azaperona,
Azaperonum,
NSC 170976,
R-1929,
1-Butanone, 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-,
Azaperonum [INN-Latin],
Azaperona [INN-Spanish],
UNII-19BV78AK7W,
1-(3-(4-Fluorobenzoyl)propyl)-4-(2-pyridyl)piperazine,
C19H22FN3O,
CCRIS 1586,
1-(4-Fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butanone,
4'-Fluoro-4-(4-(2-pyridyl)-1-piperazinyl)butyrophenone,
EINECS 216-715-8,
R 1929,
BRN 0565491,
MLS003106751,
19BV78AK7W,
CHEMBL340211,
CHEBI:88301,
1-(4-fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-1-one,
1-(4-fluorophenyl)-4-(4-(pyridin-2-yl)piperazin-1-yl)butan-1-one,
1-(4-fluorophenyl)-4-[4-(pyridin-2-yl)piperazin-1-yl]butan-1-one,
1-Butanone, 1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-,
NSC170976,
NCGC00016590-01,
Butyrophenone, 4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]-,
CAS-1649-18-9,
DSSTox_CID_25361,
DSSTox_RID_80826,
DSSTox_GSID_45361,
4'-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone,
1-(4-fluorophenyl)-4-[4-(2-pyridyl)piperazin-1-yl]butan-1-one,
1-(4-Fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-1-butanone,
BUTYROPHENONE, 4'-FLUORO-4-(4-(2-PYRIDYL)-1-PIPERAZINYL)-,
SMR001233462,
SR-05000001712,
Azaperone [USAN:INN:BAN],
azaperone(usp),
Azaperone [USAN:USP:INN:BAN],
Stresnil (TN),
Azaperone (USP/INN),
AC1Q4NJV,
Prestwick0_001117,
Prestwick1_001117,
Prestwick2_001117,
Prestwick3_001117,
Spectrum2_001250,
Spectrum3_001966,
AC1L25WI,
BSPBio_001254,
BSPBio_003566,
5-23-03-00041 (Beilstein Handbook Reference),
MLS002154163,
SCHEMBL121134,
SPECTRUM1505332,
SPBio_001160,
SPBio_003117,
BPBio1_001379,
DTXSID2045361,
CTK8E9220,
KBio3_002914,
XTKDAFGWCDAMPY-UHFFFAOYSA-N,
HMS1571O16,
HMS1922D20,
HMS2090K03,
HMS2093D03,
HMS2098O16,
HMS2230C17,
HMS3369I10,
HMS3652D15,
HMS3715O16,
Pharmakon1600-01505332,
BCP12176,
HY-B1470,
ZINC2596977,
Tox21_110512,
BBL011031,
BDBM50036733,
CCG-39158,
MFCD00866692,
NSC758969,
PDSP1_000828,
PDSP2_000815,
s4219,
STK802185,
AKOS005622715,
Tox21_110512_1,
AM84563,
API0001568,
CS-5158,
KS-5204,
MCULE-4749695585,
NSC-170976,
NSC-758969,
VA10355,
NCGC00016590-02,
NCGC00016590-03,
NCGC00016590-04,
NCGC00016590-06,
NCGC00016590-08,
NCGC00095171-01,
NCGC00095171-02,
NCGC00095171-03,
AK-60331,
AN-49615,
CC-24215,
L994,
LS-48432,
SBI-0206748.P001,
AB0014996,
TC-063579,
WLN: T6N DNTJ D3VR DF& A- BT6NJ,
AB00514057,
FT-0602908,
ST24037370,
SW196387-3,
Azaperone, VETRANAL(TM), analytical standard,
A16416,
D02620,
K-5140,
AB00514057-06,
AB00514057_07,
649A189,
A810604,
C-19900,
L000791,
I06-0254,
J-010171,
SR-05000001712-1,
SR-05000001712-3,
BRD-K45861246-001-05-0,
BRD-K45861246-001-08-4,
Azaperone, British Pharmacopoeia (BP) Reference Standard,
{4'-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone},
4'-Fluoro-4-[4-(2-pyridinyl)-1-piperazinyl]butyrophenone,
Azaperone, European Pharmacopoeia (EP) Reference Standard,
Azaperone, United States Pharmacopeia (USP) Reference Standard,
Butyrophenone, {4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]-},
1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-1-butanon,
1-(4-Fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butznone,
1-(4-fluoro-phenyl)-4-(4-pyridin-2-yl-piperazin-1-yl)-butan-1-one,
1-Butanone, {1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-},
1-(4-Fluoro-phenyl)-4-(4-pyridin-2-yl-piperazin-1-yl)-butan-1-one(Azaperone),
4 inverted exclamation mark -fluoro-4-(4-(2-pyridyl)-1-piperazinyl)-butyrophenon,
4 inverted exclamation marka-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone,
D0Q7FM,
Azaperone [USAN:BAN:INN],
Azaperone, 98% - 10MG 10mg,
CID15443,
C19-H22-F-N3-O,
B1668,
R1929,
D001376,
|
| Complexity | 390 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 327.175g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 24 |
| Hydrogen Bond Acceptor Count | 5 |
| Hydrogen Bond Donor Count | 0 |
| Isotope Atom Count | 0 |
| Molecular Weight | 327.403g/mol |
| Monoisotopic Mass | 327.175g/mol |
| Rotatable Bond Count | 6 |
| Topological Polar Surface Area | 36.4A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.3 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H301 |
| Packing Group | Ⅲ |
| Precautionary statements | P301+P310 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

